Suppr超能文献

Bat3 通过抑制 Tim-3 介导的细胞死亡和衰竭来促进 T 细胞反应和自身免疫。

Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.

机构信息

Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Nat Med. 2012 Sep;18(9):1394-400. doi: 10.1038/nm.2871.

Abstract

T cell immunoglobulin and mucin domain–containing 3 (Tim-3) is an inhibitory receptor that is expressed on exhausted T cells during infection with HIV-1 and hepatitis C virus. By contrast, Tim-3 expression and function are defective in multiple human autoimmune diseases. However, the molecular mechanisms modulating Tim-3 function are not well understood. Here we show that human leukocyte antigen B (HLA-B)-associated transcript 3 (Bat3) binds to, and represses the function of, Tim-3. Bat3 protects T helper type 1 (TH1) cells from galectin-9–mediated cell death and promotes both proliferation and proinflammatory cytokine production. Bat3-deficient T cells have elevated expression of exhaustion-associated molecules such as Tim-3, Lag3, Prdm1 and Pbx3, and Bat3 knockdown in myelin-antigen–specific CD4+ T cells markedly inhibits the development of experimental autoimmune encephalomyelitis while promoting the expansion of a dysfunctional Tim-3hi, interferon-γ (IFN-γ)loCD4+ cell population. Furthermore, expression of Bat3 is reduced in exhausted Tim-3+ T cells from mouse tumors and HIV-1–infected individuals. These data indicate that Bat3 acts as an inhibitor of Tim-3–dependent exhaustion and cell death. Bat3 may thus represent a viable therapeutic target in autoimmune disorders, chronic infections and cancers.

摘要

T 细胞免疫球蛋白和粘蛋白结构域 3(Tim-3)是一种抑制性受体,在感染 HIV-1 和丙型肝炎病毒时表达于耗尽的 T 细胞上。相比之下,Tim-3 的表达和功能在多种人类自身免疫性疾病中存在缺陷。然而,调节 Tim-3 功能的分子机制尚不清楚。在这里,我们表明人类白细胞抗原 B(HLA-B)相关转录物 3(Bat3)与 Tim-3 结合并抑制其功能。Bat3 可保护辅助性 T 细胞 1(TH1)细胞免受半乳糖凝集素-9 介导的细胞死亡,并促进增殖和促炎细胞因子的产生。Bat3 缺陷型 T 细胞高表达衰竭相关分子,如 Tim-3、Lag3、Prdm1 和 Pbx3,Bat3 在髓鞘抗原特异性 CD4+T 细胞中的敲低可显著抑制实验性自身免疫性脑脊髓炎的发展,同时促进功能失调的 Tim-3hi、干扰素-γ(IFN-γ)loCD4+细胞群的扩张。此外,在来自小鼠肿瘤和 HIV-1 感染个体的耗尽的 Tim-3+T 细胞中,Bat3 的表达减少。这些数据表明,Bat3 作为 Tim-3 依赖性衰竭和细胞死亡的抑制剂发挥作用。Bat3 因此可能成为自身免疫性疾病、慢性感染和癌症的可行治疗靶点。

相似文献

2
A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis.
FASEB J. 2014 Nov;28(11):5000-9. doi: 10.1096/fj.14-258194. Epub 2014 Aug 4.
4
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function.
Sci Immunol. 2022 Mar 11;7(69):eabm0631. doi: 10.1126/sciimmunol.abm0631.
5
A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis.
J Immunol. 2019 Jul 1;203(1):76-83. doi: 10.4049/jimmunol.1801625. Epub 2019 May 29.
6
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
Nature. 2015 Jan 15;517(7534):386-90. doi: 10.1038/nature13848. Epub 2014 Oct 26.
8
Expression Analysis of Fyn and Bat3 Signal Transduction Molecules in Patients with Chronic Lymphocytic Leukemia.
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2615-2621. doi: 10.31557/APJCP.2020.21.9.2615.
9
TIM-3 does not act as a receptor for galectin-9.
PLoS Pathog. 2013 Mar;9(3):e1003253. doi: 10.1371/journal.ppat.1003253. Epub 2013 Mar 21.
10
Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice.
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12105-10. doi: 10.1073/pnas.1120914109. Epub 2012 Jul 5.

引用本文的文献

4
Controlling T cell-tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy.
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2500589122. doi: 10.1073/pnas.2500589122. Epub 2025 Jul 8.
5
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine.
Neoplasia. 2025 Jun 30;67:101206. doi: 10.1016/j.neo.2025.101206.
7
Negative Immune Checkpoint Inhibitors.
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
8
Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma (ccRCC).
Int J Mol Sci. 2025 Jun 11;26(12):5577. doi: 10.3390/ijms26125577.

本文引用的文献

1
Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways.
Mol Cell Biol. 2011 Oct;31(19):3963-74. doi: 10.1128/MCB.05297-11. Epub 2011 Aug 1.
2
Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease.
Scand J Gastroenterol. 2011 Jun;46(6):701-9. doi: 10.3109/00365521.2011.568518. Epub 2011 Apr 5.
3
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.
Blood. 2011 Apr 28;117(17):4501-10. doi: 10.1182/blood-2010-10-310425. Epub 2011 Mar 8.
4
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.
J Exp Med. 2010 Sep 27;207(10):2187-94. doi: 10.1084/jem.20100643. Epub 2010 Sep 6.
6
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14733-8. doi: 10.1073/pnas.1009731107. Epub 2010 Aug 2.
7
Constitutively active Lck kinase in T cells drives antigen receptor signal transduction.
Immunity. 2010 Jun 25;32(6):766-77. doi: 10.1016/j.immuni.2010.05.011. Epub 2010 Jun 11.
8
Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
J Immunol. 2010 May 1;184(9):4696-707. doi: 10.4049/jimmunol.0903478. Epub 2010 Mar 29.
9
T-cell exhaustion: characteristics, causes and conversion.
Immunology. 2010 Apr;129(4):474-81. doi: 10.1111/j.1365-2567.2010.03255.x. Epub 2010 Feb 23.
10
Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.
J Immunol. 2009 Dec 1;183(11):7169-77. doi: 10.4049/jimmunol.0901906. Epub 2009 Nov 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验